Short Interest in JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Declines By 12.1%

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) saw a large decrease in short interest in August. As of August 31st, there was short interest totalling 309,700 shares, a decrease of 12.1% from the August 15th total of 352,400 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.

JCR Pharmaceuticals Price Performance

Shares of OTCMKTS:JCRRF remained flat at $4.70 during midday trading on Tuesday. The company has a 50-day moving average of $4.53 and a two-hundred day moving average of $5.18. JCR Pharmaceuticals has a 12-month low of $4.30 and a 12-month high of $4.70.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.